130 related articles for article (PubMed ID: 37061221)
1. Giant Mucinous Borderline Ovarian Tumor Presenting Alongside Perforated Peptic Ulcers.
Pence S; Christiansen A; George E
J Obstet Gynaecol Can; 2024 Mar; 46(3):102114. PubMed ID: 37061221
[No Abstract] [Full Text] [Related]
2. Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.
Ozer H; Yenicesu G; Arici S; Cetin M; Tuncer E; Cetin A
Diagn Pathol; 2012 Sep; 7():124. PubMed ID: 22995373
[TBL] [Abstract][Full Text] [Related]
3. A patient with a mucinous borderline ovarian tumor after fertility-sparing surgery in whom puncture fluid cytology on oocyte retrieval led to a diagnosis of recurrence.
Yoshiba T; Takei Y; Manaka Y; Suzuki T; Fujiwara H
J Obstet Gynaecol Res; 2022 Oct; 48(10):2635-2639. PubMed ID: 35871537
[TBL] [Abstract][Full Text] [Related]
4. Borderline Mucinous Tumor With Granulosa Cell Proliferation.
Chougule A; Singh P
Int J Gynecol Pathol; 2017 May; 36(3):270-272. PubMed ID: 27801757
[No Abstract] [Full Text] [Related]
5. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
[TBL] [Abstract][Full Text] [Related]
6. High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.
Hatano Y; Tamada M; Asano N; Hayasaki Y; Tomita H; Morishige KI; Hara A
Diagn Pathol; 2019 Jan; 14(1):4. PubMed ID: 30636633
[TBL] [Abstract][Full Text] [Related]
7. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors.
Lu Z; Li B; Gu C
J Int Med Res; 2019 Oct; 47(10):4895-4903. PubMed ID: 31432738
[TBL] [Abstract][Full Text] [Related]
9. Incidental finding of huge ovarian borderline mucinous tumour during management of laparoscopic gastric banding port infection.
Naji O; Hussain A; Abdallah Y
J Obstet Gynaecol; 2010 Feb; 30(2):212-3. PubMed ID: 20143997
[No Abstract] [Full Text] [Related]
10. Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.
Hada T; Miyamoto M; Ishibashi H; Kawauchi H; Soyama H; Matsuura H; Sakamoto T; Kakimoto S; Aoyama T; Iwahashi H; Suzuki R; Tsuda H; Takano M
In Vivo; 2020; 34(3):1341-1346. PubMed ID: 32354928
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal woman with 24 kilograms ovarian mucinous cystadenoma: a rare case report.
Halani D; Jaiswal A
Pan Afr Med J; 2023; 44():42. PubMed ID: 37070025
[TBL] [Abstract][Full Text] [Related]
12. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.
Nasioudis D; Alevizakos M; Holcomb K; Witkin SS
Maturitas; 2017 Feb; 96():45-50. PubMed ID: 28041594
[TBL] [Abstract][Full Text] [Related]
13. Synergy of the microRNA Ratio as a Promising Diagnosis Biomarker for Mucinous Borderline and Malignant Ovarian Tumors.
Dolivet E; Gaichies L; Jeanne C; Bazille C; Briand M; Vernon M; Giffard F; Leprêtre F; Poulain L; Denoyelle C; Vigneron N; Fauvet R
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958997
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound, macroscopic and histological features of borderline ovarian tumors.
Verdecchia V; Romeo P; Arciuolo D; Moro F
Int J Gynecol Cancer; 2021 Feb; 31(2):302-303. PubMed ID: 32948639
[No Abstract] [Full Text] [Related]
15. Primary squamous cell carcinoma of the ovary accompanied by transition of a mucinous borderline ovarian tumor.
Bak S; Hong JY; Lee JW; Im S; Park DC
J Int Med Res; 2023 Feb; 51(2):3000605221098177. PubMed ID: 36734245
[TBL] [Abstract][Full Text] [Related]
16. Borderline mucinous ovarian tumor presenting as pseudo-Meigs' syndrome.
Chen YY; Hsiao SM; Hsu YP; Lin HH; Wei MC
J Obstet Gynaecol Res; 2013 Jan; 39(1):434-6. PubMed ID: 22672527
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonic and pathological characteristics of ovarian mucinous cystic tumors with malignant mural nodules: Two cases report.
Zhang Y; Yuan Z; Sun K; Li P
Medicine (Baltimore); 2017 Nov; 96(45):e8636. PubMed ID: 29137100
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: A case series with a review of the literature.
Ludovisi M; Foo X; Mainenti S; Testa AC; Arora R; Jurkovic D
J Clin Ultrasound; 2015; 43(9):573-7. PubMed ID: 25706035
[TBL] [Abstract][Full Text] [Related]
19. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I; Darb-Esfahani S; Sehouli J
BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tumor markers and clinicopathological features in serous and mucinous borderline ovarian tumors.
Alanbay I; Aktürk E; Coksuer H; Ercan CM; Karaşahin E; Dede M; Yenen MC; Ozan H; Dilek S
Eur J Gynaecol Oncol; 2012; 33(1):25-30. PubMed ID: 22439401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
